Skip to main content

Table 5 Productivity losses due to excess deaths attributable to resistant infection (Indirect Cost)

From: Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use

  Thailand United States
S. aureus E. coli K. pneumoniae A. baumanii P. aeruginosa S. aureus E. coli K. pneumoniae A. baumanii P. aeruginosa
Excess deaths 2799 597 288 15,168 270 11,285 690 1620 500 440
GDP/capita (US$)a 5907 57,466
Indirect Cost (million US$) 150.5 32.1 15.5 815.3 14.5 5901.4 360.8 847.2 261.5 230.1
RMf 0.37 0.27 0.35 0.45 0.52 0.37 0.27 0.35 0.45 0.52
Indirect cost due to human consumption (million US$) 55.7 8.7 5.4 366.9 7.6 2183.5 97.4 296.5 117.7 119.7
  1. a Data from World Bank